Anyplex™Ⅱ HPV28 Detection simultaneously detects, differentiates and quantifies 28 distinct HPV genotypes (19 high-risk and 9 low-risk) responsible for cervical cancer and/or sexually transmitted infections. Based on Seegene’s proprietary DPO™ and TOCE™ technologies, this multiplex assay performs on real-time PCR instrument and provides high sensitivity and specificity genotyping information of infected 28 HPV types in a single reaction

Detection and identification of 19 high-risk HPV and 9 low-risk HPV in a single reaction

Automated data interpretation and LIS interlocking with Seegene Viewer

Utilization of the UDG system to prevent carry-over contamination

Quantitative analysis by cyclic-CMTA

Convenient workflow using Seegene’s automated one platform

Whole process validation from extraction to PCR by whole process control

Assistant of appropriate treatment and management for co-infection

Multiplex real-time PCR with high sensitivity and specificity by utilization of DPO™ and TOCE™ technologies

Useful tool for surveillance and infection control
The result represents co-infection that HPV 16 is high (+++) in the HEX channel, HPV 52 is high(+++) in the Cal Red 610 channel, HPV 35, 61 are high (+++) in the Quasar 670 channel and HPV 40 is intermediate (++) in the Quasar 705 channel .
- Prevalence of human papillomavirus infection among women in rural Nepal
- Human Papillomavirus Prevalence and Type Distribution Among 968 Women in South Korea
- Use of swabs for dry collection of selfsamples to detect human papillomavirus among Malagasy women
- Evaluation of HPV genotyping assays for archival clincal smaples
- Clincal validation of the Anyplex II HPV HR Detection for the Cervical Cancer Screening
- A case of HPV-53-related cervical cancer in an elderly patient
- High prevalence of hpv multiple genotypes in women with persistent chlamydia trachomatis infection